After a public records request, student journalists at the University of North Carolina at Chapel Hill, exposed internal faculty dissent over reopening plans and advance warning from epidemiologists long before school closed for in-person learning early in the semester. “You could see a direct line from the decisions they made in May,” said Elizabeth Moore, 20, a senior editor at The Daily Tar Heel, the student paper. “That ended up causing some harm. A lot of people got sick, and people got displaced from dorms.” A surge in daily infections is forcing a reckoning in the Netherlands, which has long prided itself on efficient government — some say to the point of smugness. And, as local journalists, they’re also telling the story of their community as people try to adjust to life during the virus. “You’re not parachuting in,” Oyin Adedoyin, 21, the editor in chief of The Spokesman, the student newspaper at Morgan State University, Maryland’s largest historically Black university. She partnered with the Poynter Institute to report on health disparities in Baltimore’s Black community. “You literally live it.” Resurgences When the election is decided: If Mr. Trump prevails, Americans can expect him to double down on prioritizing the economy over public health, demanding that schools reopen, and dismissing mask wearing and restrictions on large gatherings in favor of promises of therapeutics and vaccines.If Joe Biden is elected, he would prepare to put his plan in place for ramping up testing, ensuring a steady supply of protective equipment, distributing a vaccine when available, securing money from Congress for schools and hospitals, and possibly putting in place a national mask mandate.Student journalists find Covid scoopsAs local news hollows out, college journalists are sometimes the only reporters left in town. Now, as American colleges have become a major source of coronavirus outbreaks, with at least 214,000 cases linked to campuses, they are on the front lines of a vital national story. – Advertisement – Often, they have to report on their own campus communities, breaking news about poorly organized administrative responses and irresponsible revelers. “It’s up to us to report on it,” said Eli Hoff, 19, the managing editor of The Maneater, a student newspaper at the University of Missouri. Before the semester even started, Hoff and his colleagues broke news about outbreaks in fraternities, which drew prank calls and harassment by Greek members.“It’s weird being a student reporting on other students,” he said. “Not only am I a student reporting on them, but their actions have such a personal impact on me.” The coming months look grim Votes are still being counted in the presidential race, but no matter who wins, President Trump will lead the country’s response to the virus during the next few months — which look likely to be the bleakest and potentially deadliest period of the pandemic.Infections are escalating toward a record-breaking 100,000 cases a day, hospitals are strained and deaths are rising. At least 22 states have added more cases over the last week than in any other weeklong stretch of the pandemic, and the country recorded 1,130 deaths on Tuesday, one of the highest daily totals since the surge this summer ended.- Advertisement – – Advertisement – One person Mr. Trump does listen to is Dr. Scott Atlas, a radiologist who now serves as his coronavirus adviser. Dr. Atlas has questioned the effectiveness of mask wearing and has suggested that the government should let the pandemic run its course — a position that has been adopted by some Republican governors — and one that health experts and epidemiologists say would lead to hundreds of thousands of unnecessary deaths.- Advertisement – France, facing a backlash from small businesses closed during a second national lockdown, has ordered big retailers to stop selling books, clothes, toys, flowers and other nonessential items. The order set off chaos and confusion. El Paso counted 3,100 cases, a record high, and its hospitals are reaching a breaking point, the El Paso Times reports. Kenya, where cases are rising, extended a curfew and banned political gatherings. Here’s a roundup of restrictions in all 50 states.What else we’re followingWhat you’re doingThis pandemic has made it close to impossible to communicate with our 93-year-old deaf and blind aunt, who is in a nursing home. We used to hug and touch her to get her attention but now that is not an option. So we use her favorite foods and treats to make her aware that we still love her and care enough to visit. The staff passes her blueberries, milk chocolate, potato chips, and cold water from home in a special container she is used to. Then she knows we are somewhere near by. Sometimes her sock-covered toes stick out under the Plexiglas shield so we can tickle her and get her laughing! It is so good to see her smile and chuckle.— Patricia Alt, Madison Township, Pa.Let us know how you’re dealing with the pandemic. Send us a response here, and we may feature it in an upcoming newsletter.Sign up here to get the briefing by email.Email your thoughts to [email protected] Did a friend forward you the briefing? Sign up here. In Europe, which is being hit by a similarly ferocious fall wave, many countries have announced fresh restrictions in the last several days to slow the spread of the virus. But there is deep skepticism that the American president will follow suit in the coming weeks.Even if Mr. Trump is not re-elected, he will keep his job until Jan. 20 and he has been sticking to his message that the country is “rounding the corner” on the virus. He has largely shut down the White House Coronavirus Task Force and has stopped listening to his health officials.
– Advertisement – But lingering uncertainty over the outcome of the 2020 U.S. presidential election means that it’s unlikely another coronavirus stimulus package will be agreed upon in the near term.“With the U.S. election gradually drawing to a close, the details of a fiscal stimulus could become clearer. Any such package could see weakening of the U.S. dollar and further increases in the bitcoin price going forward,” Peters said.Meanwhile, analysts have cheered moves from the likes of PayPal and Facebook in the cryptocurrency space lately.- Advertisement – – Advertisement – PayPal said it would let its customers buy and sell digital assets like bitcoin and ether through its digital wallet and eventually use them for shopping, while Facebook is developing its libra digital currency with a Switzerland-based consortium called the Libra Association.Still, regulators continue to scrutinize the cryptocurrency industry. Bitcoin’s network doesn’t require a central authority to maintain it, and officials have expressed concern with its use in illicit transactions. On Thursday, the U.S. Department of Justice said it had seized $1 billion worth of bitcoin believed to be linked to Silk Road, the now-defunct online black market. Bitcoin has been on a tear in 2020, more than doubling in value year-to-date. Its meteoric rise comes on the back of unprecedented stimulus from global governments and central banks during the coronavirus pandemic, which some industry insiders believe has made the virtual currency more attractive than fiat currencies like the dollar.“Bitcoin’s creation was in part due to fears that increased fiscal stimulus is devaluing currencies globally,” said Simon Peters, a cryptoasset analyst at investment platform eToro. “As a result, when central banks announce extensive plans to pump money into economies, many investors in the crypto community take this as a major bitcoin buy signal.”Investors are awaiting the latest monetary policy announcement from the Federal Reserve, with the U.S. central bank expected to keep overnight rates close to zero and reiterate the need for more fiscal stimulus. Bitcoin‘s price climbed above $15,000 on Thursday, hitting a level not seen since January 2018 amid U.S. presidential election uncertainty.The world’s best-known cryptocurrency was last trading almost 9% higher at a price of $15,233, according to data from industry website CoinDesk.- Advertisement –
Derby’s prospective takeover by Abu Dhabi royal family member Sheikh Khaled Zayed Bin Saquer Zayed Al Nayhan has been approved by the English Football League. Sheikh Khaled, who is the cousin of Manchester City owner Sheikh Mansour, fronts Bin Zayed International LLC and previously made high-profile bids to buy Premier League clubs Liverpool and Newcastle.- Advertisement – Former Derby head coach Steve McClaren says the club and its boss Phillip Cocu are ‘underachieving’ with the Rams second from bottom in the Championship. – Advertisement – – Advertisement – The impending deal, which has been agreed in principle following discussions with Derby owner Mel Morris, was discussed at an EFL board meeting on Thursday.Derby said in a club statement: “Derby County Football Club’s Owner and Executive Chairman Mel Morris CBE has been in discussion with Derventio Holdings (UK) Limited since May in relation to taking over the ownership the club. 0:55 Derby are second-bottom of the Championship table after a six-game run without a win since the October international break, form that has increased the scrutiny on manager Phillip Cocu.Dutchman Cocu, who has won just won of his opening 10 league games this season, will not be in the dugout against Barnsley on Saturday as he and Morris are self-isolating after club chief executive Stephen Pearce tested positive for coronavirus.Cocu and Morris, who has already publicly backed the Dutchman earlier this season, both came into contact with Pearce during individual meetings. “These talks progressed to the point where a deal has, in principle, been agreed between the two parties.“The club’s submission under the Owners and Director’s test for Derventio was approved by the EFL board on Thursday.Derventio Holdings (UK) Limited, who’s ultimate controlling entity is Bin Zayed International LLC, owned by Sheikh Khaled Zayed Bin Saquer Zayed Al Nayhan, may now proceed with the transaction, which is a expected to close very soon.” Image:Wayne Rooney is the Derby captain – Advertisement –
David Graham at The Atlantic:One Republican refrain now is that the declaration of Biden’s victory is a media creation and not an official one, which is true. Real deadlines loom ahead: States will begin certifying election results, and on December 14 the Electoral College will meet. At some point, most of these people will have to bend to reality. Maybe not the president, though. If one lesson of the past four years is that it’s no fun to be a Republican on Trump’s bad side, another one is that anyone waiting for Trump to acknowledge reality could be waiting forever.- Advertisement – His refusal to accept the results, even though it wasn’t a particularly close election, has taken an insidious new turn now that his political appointee in charge of authorizing the start of the Biden transition is refusing to give the okay. The delay undercuts all aspects of government’s functioning and leaves the country needlessly vulnerable to security threats. At The Week, Damon Linker writes that just because it doesn’t matter if Trump never concedes, we should still be outraged at what’s happening:Trump’s refusal to concede could nonetheless plant seeds of a future in which such processes of transitions are far from inevitable. If he begins to travel the country over the coming weeks, holding rallies during which he spreads the lie of a stolen election to cheering throngs of supporters, that could do even greater damage. That’s because words matter in democratic politics. By casting doubt on the legitimacy of the Nov. 3 election, Trump conveys the message to his most devoted followers that the political system of the United States is fundamentally rigged against them. And by implying that Philadelphia, with its large Black population, is the primary source of the fraud that will deny them their rightful political power, he interweaves a story of injustice and grievance with outright racism.On a final note, let’s not also forget that Obamacare is at the Supreme Court today. Here’s analysis from Abbe Gluck, writing at The Washington Post:Today, the newly constituted Supreme Court will hear a challenge to the Affordable Care Act — the seventh in eight years. It is the most challenged statute in modern American history. In addition to the Supreme Court cases, there have been more than 1,700 cases in the lower courts; Republicans in Congress have tried more than 70 times to repeal it; the Trump administration has engaged in an unprecedented array of executive actions to undermine the insurance markets and financially starve the law; red states rebelled against it from the day it was passed; and state initiatives have been enacted by supporters to force states to effectuate it.And still the Affordable Care Act, which may be the most resilientstatute in American history, has done more than survive: It has transformed our health care system and the way Americans think about their right to care. Even prominent Republicans like Eric Cantor, the former House majority leader, have concluded that we cannot go back to the era before the law, when millions fewer people had access. Yet here we are again, at the Supreme Court, for a case so weak that even many conservative legal scholars who oppose the law also oppose the lawsuit. – Advertisement – So this will be President Trump’s parting gift to the nation: He is deliberately sabotaging the national security of the United States. Dana Milbank writes about Trump’s sabotaging of government:
According to the Centers for Disease Control and Prevention (CDC), cidofovir is a second-line treatment, after vaccinia immune globulin, for severe complications of smallpox vaccination. The drug can be used for that purpose under an investigational new drug protocol sponsored by the CDC. Currently it is available only in an IV formulation. The mice were then treated with 1% cidofovir cream applied to the skin or with intravenous cidofovir. Control mice were treated with a placebo. The topical cidofovir was given twice daily for a week after virus exposure, while the IV treatments were given every 3 days for 21 days. All the mice died of spreading vaccinia infections, but those treated with either formulation of cidofovir survived significantly longer than the control mice. The topical drug was much more effective than the parenteral form in limiting the size and number of skin lesions, a finding that was explained by markedly lower levels of virus (viral titers) in the lesions in mice treated with the cream. “The 1% cidofovir formulation appeared to be well tolerated by the mice,” the report states. “Topical treatment may not necessarily be safe for humans, because of potential to cause kidney damage and because the drug has been shown to be absorbed into the body by the topical route.” The researchers also looked at whether the combination of topical and IV treatment works better than either treatment alone, with treatment starting 5 days after infection. Mice that received the combined treatment survived a mean of 28.3 days, compared with 19.8 days for the topical treatment alone and 21.4 days for the IV treatment alone. Oct 11, 2004 (CIDRAP News) The antiviral drug cidofovir is one of very few agents used to treat serious side effects of smallpox vaccination. In a recent study, a topical form of cidofovir worked better than an intravenous formulation to protect mice from the effects of vaccinia, the smallpox vaccine virus. Donald F. Smee and colleagues at Utah State University in Logan treated several groups of mice with cyclophosphamide to cripple their immune systems and then applied vaccinia to scratches on the mice’s skin. The study is reported in a recent issue of Journal of Infectious Diseases. Smee DF, Bailey KW, Wong M, et al. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. J Infect Dis 2004 15 Sep;190(6):1132-39 [Abstract] The authors add that using a topical antiviral drug may not be practical for treating actual smallpox infections, since the sores spread over the whole body. “However, topical treatment should definitely be considered for localized infections, particularly for those complications arising from smallpox vaccination.” See also: CIDRAP News article, “CDC offers clinicians guidance on smallpox vaccination reactions”
Jul 7, 2006 (CIDRAP News) – Dengue fever in US travelers to tropical regions has registered a sharp upsurge, with as many cases in 2005 as in the previous 5 years combined, according to the Centers for Disease Control and Prevention. A report in the Jun 30 issue of Morbidity and Mortality Weekly Report summarizes the 96 cases that were reported in 2005. An accompanying editorial note says that 98 cases were diagnosed in 1999 through 2004. Among 199 travelers in 2005 whose clinical symptoms suggested dengue fever, 96 cases were confirmed on the basis of serum samples. Of the patients with confirmed cases, 17 (18%) were hospitalized, including 1 who died. The fatality occurred in a previously healthy 28-year-old woman who had spent a week in Mexico. Dengue fever is a flu-like illness transmitted by certain special of Aedes mosquitoes. It involves headaches, rashes, cramps, and back and muscle pain. Dengue hemorrhagic fever, a potentially deadly complication, is characterized by high fever, bleeding manifestations, thrombocytopenia, increased vascular permeability, and in particularly severe cases, circulatory failure. There is no preventive vaccine available. The CDC’s note says that incidences of dengue and dengue hemorrhagic fever are increasing in tropical areas of the world. They attribute the increase to waning support for mosquito-control programs, urbanization of the tropics, increasing human populations, and increased use of nonbiodegradable products that provide mosquito breeding areas. CDC. Travel-associated dengue—United States, 2005. MMWR 2006 Jun 30;55(25):700-2 [Full text] CDC notes that in terms of being widely representative of travel-related dengue, the current report findings are limited by probable underreporting of cases (dengue is not a nationally notifiable disease and surveillance is passive) and by the fact that travel history and clinical information were not available in all cases. People who travel to areas where dengue is endemic are warned to avoid exposure to mosquitoes by using repellents, wearing protective clothing, and remaining in well-screened or air-conditioned areas. Of the 96 patients with dengue, 53 (55%) were female. Median age was 43 years for the 83 patients in whom age was reported. Travel destinations for the 2 weeks before disease onset were available for 73 patients; locations included Mexico (32), Central America (19), the Caribbean (16), and Asia (6). See also: CDC information on dengue fever and dengue hemorrhagic feverhttp://www.cdc.gov/dengue/
Apr 27, 2007 (CIDRAP News) – A committee that reviews medical product applications for the European Union (EU) yesterday recommended approval of a cell-based seasonal influenza vaccine made by Novartis, improving the company’s chance of becoming the first to market a flu vaccine grown in cell culture instead of in eggs.The Committee for Medicinal Products for Human Use (CHMP), which reviews applications for 27 EU countries, found that Novartis’s Optaflu vaccine, given to more than 3,400 people during clinical studies, met the CHMP’s immunogenicity criteria, the Swiss-based company said in a press release today.In a statement released yesterday, the CHMP said it concluded there is “a favourable benefit to risk ratio” for Optaflu and therefore recommended its authorization. The vaccine is intended for adults.The European Commission is not bound by the committee’s recommendations but usually follows them, delivering a decision within 2 to 3 months, Novartis said.If the European Commission approves Optaflu, it may become the first seasonal flu vaccine made with cell-culture production techniques to go on the market. Flu vaccines have been grown in chicken eggs since the 1950s, but several companies are developing processes for growing them in laboratory cell cultures. The Optaflu vaccine is grown in canine kidney cells.In 2001, the European Commission approved a cell-culture version of Solvay Pharmaceuticals’ Influvac flu vaccine for sale in the Netherlands, but the company has not yet marketed it. The company Web site says that market introduction of the vaccine is expected “in the near future.””Optaflu contributes to meeting the growing demand for seasonal influenza vaccines, and this production technology offers the potential for quick scale-up of manufacturing in the event of an influenza pandemic,” said Jörg Reinhardt, chief executive officer of Novartis Vaccines and Diagnostics, in the press release.Cell-culture production is seen as slightly faster and considerably more flexible than traditional egg-based methods. In its press release, Novartis said products made with cell-culture methods are safe for people who are allergic to eggs because they are not created with egg proteins.The new technology also offers the possibility of developing vaccine seed strains that more closely match the original “wild” virus, according to Novartis. Cell-culture methods eliminate passage of the virus through eggs, where it may need to adapt before it can replicate. The antigen in a cell-based vaccine may more closely match the wild-type virus and possibly provide a better immune response, the company said.Novartis has said that Optaflu is a subunit vaccine, meaning it contains individual viral proteins rather than whole virus particles.In a phase 3 study, conducted in Poland during the 2004-05 flu season, 1,300 volunteers between the ages of 18 and 60 and 1,354 volunteers older than 60 were randomly assigned to receive one dose of either the cell-based vaccine or an egg-based vaccine, according to a previous Novartis report.Investigators found no differences in the immunogenicity of the vaccines, both of which met CHMP criteria. Local and systemic side effects for the two vaccines were similar in both age-groups.Novartis said it anticipates applying for US licensing of its cell-based flu vaccine in 2008. The company has conducted phase 1 and 2 clinical trials of the vaccine in the United States and in July 2006 announced it would build a $600 million plant in Holly Springs, N.C., to make cell-culture flu vaccines. In May 2006 the US Department of Health and Human Services awarded Novartis a $220 million contract to develop cell-based flu vaccines, and Novartis has said the money would go toward the cost of the new facility.Depending on when its vaccine is approved by the Food and Drug Administration, the plant could begin production as early as 2011 and be ready for full production as early as 2012, with an annual output of 50 million doses of a trivalent vaccine, the company has said.In the event of a flu pandemic, the facility is designed to have the capacity to make up to 150 million monovalent (single strain) doses each year within 6 months of a pandemic declaration, Novartis said. Novartis’ other cell-based vaccine production facility is in Marburg, Germany.See also:Apr 27 Novartis press releaseOct 24, 2006 CIDRAP News article “Novartis claims success in trial of cell-based flu vaccine”Jul 18, 2006 CIDRAP News article “Novartis to build US cell-based flu vaccine plant”
As it was before announced i.e. promised, it also received official confirmation today. UHPA Days in 2019 will be held in Vinkovci. Representatives of UHPA, Tomislav Fain, president and Ivana Maltar, head of the office visited Vinkovci yesterday and today and in cooperation with TZ Vinkovci agreed to cooperate on the organization of UHPA Day in Vinkovci, which will be held from 21 to 23 March. 2019. “After an agreement with the Vinkovci Tourist Board and hoteliers, I can confirm that the UHPA Days will be in Slavonia, more precisely in the city of Vinkovci. Everyone talks a lot about Slavonia, and we initially supported the Initiative to hold the Days of Croatian Tourism in Slavonia, as well as announced that we will hold the UHPA Days in Slavonia. We promised before that we would come, and now we are just fulfilling our promise. We do not just want to talk, but we want to give our all and concretely act to better position Slavonia in terms of tourism. First of all, I think that our members should get to know this part of Croatia because many of them do not know what Slavonia has to offer, and I personally think that it can do a lot. That is why we are coming for UHPA members to get acquainted with the tourist offer of Slavonia live “Said Tomislav Fain, President of UHPA. UHPA Days is an annual meeting organized by UHPA, the largest national professional association of travel agencies, bringing together more than 150 participants, travel agencies – UHPA members, representatives of the Ministry of Tourism, Croatian Chamber of Commerce, Croatian National Tourist Board, tourism professional associations and other Croatian stakeholders. tourism sector.This is a great opportunity for the whole of Slavonia to present its tourist offer to travel agencies and meet agents and representatives of travel agencies directly on the spot.Thus, 2019 will certainly be a great positive turning point for Slavonia, since the UHPA Days and the Days of Croatian Tourism (Vinkovci, Osijek) will be held in Slavonia.RELATED NEWS:TOMISLAV FAIN, UHPA: WE SUPPORT THE INITIATIVE TO HELD TOURISM DAYS IN SLAVONIA AND I ANNOUNCE UHPA DAY 2019 IN SLAVONIA
Photo: Marko Colic / Association PO “Skrlet” Out of a total of 227 ha of vineyards in the Sisak-Moslavina County, 76 ha are under the Škrlet variety, of which 68 ha are located in Moslavina. Marko Miklaužić, Moslavina winemaker and president of the newly established Bregovita Hrvatska Association of Winemakers, pointed out that the most important thing in the organization of Bregovita Hrvatska is a common approach to marketing, marketing and co-financing of wine by the state. “Each of the counties has one representative, and he should act through local chambers of commerce and industry to local associations, which then transmit information to their members. Eg. the organization of events will no longer go through the associations that are the organizers, but will be financed through the budget of the Association of Winemakers Bregovita Croatia. This will reduce the number of organizing committees and commissions, and will bring order to the system of organization, production and placement, and prevent the so-called. gray market. Members need to understand that without organizing into such associations there is no future”Said Miklauzic. PREMIERE TASTING OF YOUNG SCARLETS AT ADVENT IN ZAGREB Visitors will have the opportunity to taste 8 young škrlets and of course the above-mentioned common wine Škrlet, a blend obtained from selected grapes from the best positions produced in a limited edition of 5000 bottles. As the president of PO “Škrlet” points out Tomislav Trdenić, they teach customers a certain standard, because the presented Škrlet is the same in each bottle and under the same label and logo (yellow ram) ” The logo, ie the yellow ram, is a synonym for škrlet, and the logo is a cluster of škrlet, ie one large cluster in the middle and two small ones, one on each side. Škrlet with a new outfit designed by Marin Šubašić, under a common brand, and we will place it on the market in a limited edition of 5000 bottles. We were the first to establish a wine production organization in Croatia in this way and we hope to be successful because otherwise we will not be competitive on the market in the future. We have a great trump card for success, and that is the autochthonous grape and wine variety “Škrlet” Trdenić pointed out and added that they have been working on branding the variety of the same name for 20 years, but also on recognizing it in the wider area of Lijepa naša. That škrlet, one of over 120 autochthonous Croatian wine varieties, unstoppably finds its deserved position on the wine list of Croatia and the world, proves as many as five medals this year from the world’s most prestigious wine evaluation Decanter, as well as numerous other awards. The seven largest wine producers in Moslavina: Ilovčak, Jaram, Florijanović, Miklaužić, Mikša, Trdenić and Voštinić-Klasnić, gathered in the Association of Production Organizations “Škrlet”, premiered a unique project in Croatia – common wine Škrlet. This is the first such wine project in Croatia, which is proof of the unity of Moslavina winemakers and is a projection of the future of Croatian viticulture and winemaking. Namely, the joint wine from the autochthonous grape variety of the same name, a blend obtained from selected grapes from the best positions they produce, was presented under a joint label in a limited edition of 5000 bottles. The best Moslavina škrlet producers gathered in the Škrlet Moslavina Association will premiere their škrlet harvest, ie the young škrlet in 2019, and the promotion will take place on December 06.12.2019, 16. in Zagreb (Forum Gallery, Teslina 17.00) starting at XNUMX:XNUMX p.m.
Guided by this, we decided to talk to Silvija Zoković about the importance of active tourism for the Croatian offer, but also about the event held on Pag and plans for similar projects in the future. As for future plans, Sylvia is full of ideas and possible projects that combine Nordic walking and tourism. “We were contacted by the staff of the Brijuni National Park to design a similar event there. Also, in Karlovac County, I would like to organize a walking event that would be held in a different place at any time of the year. There is also the idea of a ‘green heart’, ie that the City of Zagreb, Zagreb County, Krapina-Zagorje County and Sisak-Moslavina County be connected by a single heart-shaped route. For example, one ‘arm of the heart’ would go from the Zagreb Cathedral, through Sljeme, through Zaprešić, to Sisak-Moslavina County, and the other ‘arm’ would return through Marija Bistrica and back to the Cathedral in Zagreb.”, She concluded. The event lasted for three days during which walkers crossed four trails and had an unforgettable experience of walking on the moon island and tasting the famous Pag delicacies. The goal of this sports and recreational event is to promote an active lifestyle and introduce participants to the natural and cultural beauties of the town and the island of Pag as well as the gastronomic offer. “There is a large audience for this form of tourism. Now you just need to work very hard to have a quality final product – from trails, signage, maps, events… Because to offer something it has to be from head to toe in five! My dream and wish is for the whole of Croatia to be networked with Nordic walking trails and for all this to be beautifully presented.”. Photo: Nordijskohodanje.hr; Silvija Zokovic Trail of Slunj giants, Močan’s bridge on Slunjčica, Slunj When asked how she came up with the idea to connect Nordic walking with tourist facilities such as sightseeing and tasting local delicacies, Zokovic explained that she has been doing Nordic walking for fifteen years, and this activity can be seen in many destinations. “I think the best way to get to know our beautiful country is through walking, and especially through Nordic walking which in some way enhances the effects of ordinary walking and on the other hand makes it easier to move because we walk on ‘four legs’”, Explained Zokovic. Silvija Zoković, Nordijskohodanje.hr The event “Nordic Walking on the Moon Island” is planned to be repeated in the spring of next year. “This ‘zero’ year was actually a test year and the participants were thrilled so most said they were ready to come again. For a start, we aimed at our market, or our people who want to get to know Pag and enjoy nature”, Says Silvija and notes that their goal at some point, and maybe even in the spring, is to turn to foreign tourists. Silvija, with the cooperation and patronage of the Tourist Board of the city of Pag, traced as many as 150 kilometers of trails for Nordic walkers. “Considering that my father is from Pag, so I know the area very well, I suggested to the director of the tourist board Vesna Karavanić to design new trails. From this, in fact, came the idea of the event, which, in three days, gathered about 60 people and introduced them to various parts of the island.”, She said and added that everything can be seen on Pag. “Among other things, climb to the highest peak of Pag, reach the sub-Velebit channel, visit the ornithological reserves Veliko and Malo blato, walk through fields, hills, pastures along dry stone walls…”, Explains Sylvia. Active tourism is one of the most sought-after forms of tourism in the world, including in our country. And given that Croatia has so much to offer so beautiful and diverse nature, as well as numerous cultural and historical sights, promoters like Silvia and projects like “Nordic Walking on the Moon Island” must be given full support and welcomed with open arms. In September, the event “Nordic Walking on the Moon Island” was held on Pag, organized by the Tourist Board of the City of Pag and Nordic Walking.hr. Nordic walking, as one of the growing trends in active lifestyle and tourism, offers added value to hiking as well as walking for health. Silvija absolutely agrees that our tourist offer needs more active tourism content. “It is important to offer both domestic and foreign tourists such content, which in an active way have the opportunity to get to know the destination. There are a large number of people, especially in Europe, who through an active vacation want to enjoy nature, but also to get to know and experience all our cultural and historical sights.She said. Mentor trail, Dinjiška, island of Pag The event was attended by about 60 participants from the islands of Pag, Rijeka and Zagreb, Varaždin, Kutina, Đakovo, who under the leadership of Silvija Zoković from Nordijskohodanje.hr and Alan Crljenko, a passionate mountaineer and alpinist, enjoyed an active weekend.